MPS Pharmaa (BOM:531686) Beta: 0.1860 (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531686 MPS Pharmaa Ltd BOM:531686
11 GF Score
Price ₹1.99
! 3 Warning Signs
View Full Analysis

What is MPS Pharmaa Beta?

MPS Pharmaa BOM:531686 +4.74% 11 Beta is 0.1860 as of Aug. 11, 2026. GuruFocus rates BOM:531686 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-11), MPS Pharmaa's Beta is 0.1860.


MPS Pharmaa  (BOM:531686) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


MPS Pharmaa Beta Related Terms


MPS Pharmaa Beta Historical Data

* Premium members only.

The historical data trend for MPS Pharmaa's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPS Pharmaa Beta Chart

MPS Pharmaa Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.27 -0.22 0.03 0.18

MPS Pharmaa Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.05 0.29 0.11 0.18

BOM:531686 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPS Pharmaa Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's Beta distribution charts can be found below:

* The bar in red indicates where MPS Pharmaa's Beta falls into.


BOM:531686
11GF Score
MPS Pharmaa Ltd BOM:531686
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MPS Pharmaa Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1860 mean?
MPS Pharmaa (BOM:531686) has a Beta of 0.1860 as of Aug. 11, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MPS Pharmaa and its competitors.
Is MPS Pharmaa's Beta too high?
MPS Pharmaa's current Beta is 0.1860. Overall, MPS Pharmaa has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does MPS Pharmaa's Beta compare to ZTS?
MPS Pharmaa's Beta of 0.1860 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MPS Pharmaa and its competitors. MPS Pharmaa's current Beta is 0.1860. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPS Pharmaa stock overvalued right now?
MPS Pharmaa (BOM:531686) has a current Beta of 0.1860. The current Beta is 0.1860. MPS Pharmaa's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For MPS Pharmaa (BOM:531686), the current Beta is 0.1860 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPS Pharmaa Business Description

Address 19 Barakhamba Road, Connaught Place, 703, Arunachal Building, New Delhi, IND, 110001
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and exporting Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory, and antibacterials & antibiotics. Its products include Wibatol, Robial, Twosum, Arfa Gel, and others.
11GF Score

Get the complete analysis for BOM:531686

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.99
Price